Cultivation of medicinal cannabis for both medicinal and research purposes pursuant to the licences and permits issued to the Company; the development and manufacture (via third party arrangements) of finished product formulations; and the pursuit and execution of various supply and offtake agreements with third parties.
|Head Office||Port Melbourne VIC|
|Registry||Link Market Services Ltd|
|Chair Person||Allan McCallum|
|GICS Industry||Pharmaceuticals, Biotechnology & Life Sciences|
|Market Cap||$66 m|
|Shares on Issue||386 m|
|52 Week H/L|
Directors and Management
Mr Douglas (Doug) John Rathbone
Non-Executive Director 16/03/2015
Mr Rathbone is an experienced public company director and is a former Board member of the FERNZ Corporation and the CSIRO. He is Chairman of the Rathbone Wine Group and Chairman since 1 April 2018, Go Resources, Queenscliff Harbour Pty Ltd and AgBiTech. He is also a former member of the RABO Bank Advisory Board, an Honorary Life Governor of the Royal Children's Hospital and a former Director of the Burnett Centre for Medical Research. Doug brings to the Board experienced management and corporate governance skills together with a passion to grow the business having successfully transformed Nufarm to become one of the world's leading crop protection and seed companies with an global footprint. He is also member of Risk and Capital Committees.
AM, FATSE, FI ChemE, ARMIT B Comm, TTC, MAICD Male
Mr Allan D McCallum
Non-Executive Chairman,Non-Executive Director 30/01/2015
Mr McCallum has broad experience as a public company director in agribusiness and healthcare and have experience in strategy development and implementation and mergers and acquisitions. He is also member of Risk Committee and chairman of Capital Committees.
Dip.Ag Science, FAICD Male
Mr John Stewart Sharman
Non-Executive Director 27/04/2021
Mr Sharman has an international business experience as a Managing Director, CEO, CFO and non-executive director with public and private companies, including several ASX listed entities. He has an understanding of the medical manufacturing industry as well as the pharmaceutical and nutraceutical sectors. He has led businesses with operations in Australia, the UK, Europe, Asia and the USA, building distribution, sales, marketing and manufacturing networks both locally and internationally. Mr Sharman is currently the CEO of Universal Biosensors Inc (ASX:UBI). Prior to that he served 10 years as CEO of Medical Developments International (ASX:MVP). Previous roles included Managing Director of CVC Venture Managers (private equity managers), Managing Director of Vita Life Sciences (ASX:VSC) and Cyclopharm (ASX:CYC), as well as roles at PriceWaterhouseCoopers, National Australia Bank and KPMG in both London and Melbourne.
Mr Philip Robert Nicholas Jacobsen
Non-Executive Deputy Chairman,Non-Executive Director 30/01/2015
Mr Jacobsen is an experienced public company director, he co-founded Premier Artists in 1975 and The Frontier Touring Company in 1979. He serves as a director of Liberation Music, Premier Artists, The Harbour Agency and Jacobsen Bloodstock. Former Chair of MCM Entertainment Group, Philip brings to the Board a 45 plus year history of applying solid fiscal accounting perspectives to an emerging business model in a constantly changing, high demand marketplace. Philip is also an Associate of Chartered Institute of Secretaries ACIS. He is also chairman of Risk Committee.
CPA, Fin Male
Ms Jennifer (Jenni) Pilcher
Non-Executive Director 08/09/2020
Ms Pilcher has senior executive experience in the medical and biotechnology sectors and is currently the Chief Financial Officer and Company Secretary of Mach7 Technologies (ASX:M7T). She has previously held executive roles with Alchemia Limited (ASX:ACL) and Mesoblast Limited (ASX:MSB).
Mr Geoffrey(Geoff) Ronald Pearce
Non-Executive Director 11/04/2016
Mr Pearce is a entrepreneur and businessman with more than 40 years experience in the personal care industry. He established and owned Scental Pacific Pty Ltd and grew the business to become Victoria's largest manufacturer of personal care products before selling it to the Smorgon Family. He later built a contract manufacturing business, Beautiworx Australia Pty Ltd, which was also sold. Geoff currently owns The Continental Group, which supplies pharmaceutical packaging and raw materials and has developed alliances with some of the world's leading herbal extract manufacturers. He has experience in areas including manufacturing, procurement, distribution and regulatory affairs. He is also member of Risk and Capital Committees.
Top 20 Shareholders
|07/09/2021||Douglas (Doug) Rathbone||363,637||$100,000||Buy||Placement.|
|09/12/2020||Douglas (Doug) Rathbone||90,395||$64,180||Transfer||As advised by the company. Transfer of shares to Ann Rathbone from a deceased estate through grant of probate.|